161 related articles for article (PubMed ID: 23830214)
1. MicroRNA expression in Epstein-Barr virus-associated post-transplant smooth muscle tumours is related to leiomyomatous phenotype.
Jonigk D; Izykowski N; Maegel L; Schormann E; Maecker-Kolhoff B; Laenger F; Kreipe H; Hussein K
Clin Sarcoma Res; 2013 Jul; 3(1):9. PubMed ID: 23830214
[TBL] [Abstract][Full Text] [Related]
2. Tumour angiogenesis in Epstein-Barr virus-associated post-transplant smooth muscle tumours.
Jonigk D; Izykowski N; Maegel L; Schormann E; Ludewig B; Kreipe H; Hussein K
Clin Sarcoma Res; 2014 Jan; 4(1):1. PubMed ID: 24398114
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-associated smooth muscle tumours after transplantation, infection with human immunodeficiency virus and congenital immunodeficiency syndromes.
Hussein K; Maecker-Kolhoff B; Donnerstag F; Laenger F; Kreipe H; Jonigk D
Pathobiology; 2013; 80(6):297-301. PubMed ID: 24013109
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-associated smooth muscle tumors in a composite tissue allograft and a pediatric liver transplant recipient.
Conrad A; Brunet AS; Hervieu V; Chauvet C; Buron F; Collardeau-Frachon S; Rivet C; Cassier P; Testelin S; Lachaux A; Morelon E; Thaunat O
Transpl Infect Dis; 2013 Oct; 15(5):E182-6. PubMed ID: 24034213
[TBL] [Abstract][Full Text] [Related]
5. Non-canonical WNT6/WNT10A signal factor expression in EBV+ post-transplant smooth muscle tumors.
Teiken K; Kuehnel M; Rehkaemper J; Kreipe H; Laenger F; Hussein K; Jonigk D
Clin Sarcoma Res; 2018; 8():10. PubMed ID: 29881541
[TBL] [Abstract][Full Text] [Related]
6. Clinico-pathological characteristics of different types of immunodeficiency-associated smooth muscle tumours.
Hussein K; Rath B; Ludewig B; Kreipe H; Jonigk D
Eur J Cancer; 2014 Sep; 50(14):2417-24. PubMed ID: 25027306
[TBL] [Abstract][Full Text] [Related]
7. Molecular and clinicopathological analysis of Epstein-Barr virus-associated posttransplant smooth muscle tumors.
Jonigk D; Laenger F; Maegel L; Izykowski N; Rische J; Tiede C; Klein C; Maecker-Kolhoff B; Kreipe H; Hussein K
Am J Transplant; 2012 Jul; 12(7):1908-17. PubMed ID: 22420456
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a.
Motsch N; Pfuhl T; Mrazek J; Barth S; Grässer FA
RNA Biol; 2007 Nov; 4(3):131-7. PubMed ID: 18347435
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus growth/latency III program alters cellular microRNA expression.
Cameron JE; Fewell C; Yin Q; McBride J; Wang X; Lin Z; Flemington EK
Virology; 2008 Dec; 382(2):257-66. PubMed ID: 18950829
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways.
Cameron JE; Yin Q; Fewell C; Lacey M; McBride J; Wang X; Lin Z; Schaefer BC; Flemington EK
J Virol; 2008 Feb; 82(4):1946-58. PubMed ID: 18057241
[TBL] [Abstract][Full Text] [Related]
12. Dynamic expression of viral and cellular microRNAs in infectious mononucleosis caused by primary Epstein-Barr virus infection in children.
Gao L; Ai J; Xie Z; Zhou C; Liu C; Zhang H; Shen K
Virol J; 2015 Dec; 12():208. PubMed ID: 26634702
[TBL] [Abstract][Full Text] [Related]
13. A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly.
Andrade TA; Evangelista AF; Campos AH; Poles WA; Borges NM; Camillo CM; Soares FA; Vassallo J; Paes RP; Zerbini MC; Scapulatempo C; Alves AC; Young KH; Colleoni GW
Oncotarget; 2014 Dec; 5(23):11813-26. PubMed ID: 25544772
[TBL] [Abstract][Full Text] [Related]
14. As Evidence-Based Tumorigenic Role of Epstein-Barr Virus miR-BART1-3p in Neurological Tumors.
Karimzadeh M; Tabibzadeh A; Moghoofei M; Abbasi S; Sadri Nahand J; Sadeghii F; Karbalaie Niya MH; Keyvani H; Bokharaei-Salim F; Esghaei M; Esghaei M
Asian Pac J Cancer Prev; 2021 Jan; 22(1):257-266. PubMed ID: 33507707
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.
Motsch N; Alles J; Imig J; Zhu J; Barth S; Reineke T; Tinguely M; Cogliatti S; Dueck A; Meister G; Renner C; Grässer FA
PLoS One; 2012; 7(8):e42193. PubMed ID: 22870299
[TBL] [Abstract][Full Text] [Related]
16. miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas.
Cao P; Zhang M; Wang L; Sai B; Tang J; Luo Z; Shuai C; Zhang L; Li Z; Wang Y; Li G; Xiang J
BMC Cancer; 2018 Dec; 18(1):1293. PubMed ID: 30594162
[TBL] [Abstract][Full Text] [Related]
17. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
[TBL] [Abstract][Full Text] [Related]
18. PECULIARITIES OF MIR-146A AND MIR-155 EXPRESSION IN PATIENTS WITH ALLERGOPATHY IN COMBINATION WITH CHRONIC EPSTEIN-BARR VIRUS INFECTION IN LATENT AND ACTIVE PHASES.
Zubchenko S; Maruniak S; tYuriev S; Sharikadze O
Georgian Med News; 2019 May; (290):69-73. PubMed ID: 31322518
[TBL] [Abstract][Full Text] [Related]
19. The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.
Forte E; Salinas RE; Chang C; Zhou T; Linnstaedt SD; Gottwein E; Jacobs C; Jima D; Li QJ; Dave SS; Luftig MA
J Virol; 2012 Jun; 86(12):6889-98. PubMed ID: 22496226
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
